- Text-only version of this website
- Skip navigation
- Home page
- What's new
- Contact Webmaster
- Website policies
- Disability services
UF genetics expert Patrick Concannon, Ph.D., is part of group that has homed in on the genes suspected in Type 1 diabetes. “It’s a game-changer,” he said.Read More
Results from a UF Health pilot study have led to a new national trial investigating a combination treatment for individuals newly diagnosed with Type 1 diabetes.Read More
A new treatment that may reverse the effects of the most common type of lupus has shown promising results after undergoing early testing by a team of researchers at UF Health.Read More
Genetics breakthrough will boost diabetes research1
Combination therapy for diabetes2
Diabetes drug shows early promise as treatment for lupus3
UF genetics expert Patrick Concannon, Ph.D., is part of group that has homed in on the genes suspected in Type 1 diabetes. “It’s a game-changer,” he said.
A new treatment that may reverse the effects of the most common type of lupus has shown promising results after undergoing early testing by a team of researchers at UF Health.
Congratulations to Dr. Benjamin Keselowsky, associate professor in the Department of Biodmedical Engineering, has been named a UF Research Foundation Professor for 2015-2018. Professor Keselowsky is using a new $1.5M grant from the NIDDK to research novel methods for restoring cell function in type 1 diabetes (T1D) without the use of immunosuppresive drugs.
UF Professor and Extension Nutrition Specialist Linda B. Bobroff, Ph.D., RD, provides leadership for "Take Charge of Your Diabetes," as well as diabetes education and wellness initiatives in partnership with county Extension faculty throughout Florida. Based on recent success, UF/IFAS Extension is launching a new online program for cancer prevention. Read more.
Congrats to Dr. Cusi! The 2015 recipient of the UF College of Medicine Faculty Research Award in Clinical Science. Dr. Cusi is the principal investigator of a number of ongoing clinical research projects. His grants focus on cutting-edge research in adult endocrinology, diabetes and metabolism, both on clinical and basic research aspects related to the role of obesity and lipotoxicity in the development of Type 2 diabetes and its complications. Read more.
Diamyd Medical, a Swedish medical research company, annouced that it will join a research initiative launched by JDRF aimed at increasing the understanding of the natural progression of type 1 diabetes in order to transform and accelerate drug development for the disease. Diamyd Medical will contribute data that will be made available to industry and academia partners through an open access database together with similar data from other late stage type 1 diabetes studies.
Affiliate diabetes researcher Rhonda Cooper-DeHoff, UF College of Pharmacy, has received the American College of Cardiology’s 2015 Distinguished Associate Award. Dr. Cooper-DeHoff’s research emphasizes achieving healthy blood pressure control through reduction of risk factors for hypertension and type 2 diabetes. Read more.
Results from a UF diabetes research project have been selected for presentation at the upcoming American Diabetes Association 75th Scientific Sessions conference in June. Ashby Walker, Ph.D., Department of Health Outcomes and Policy, will present the study findings, entitled "Making a Difference with Behavioral Science." Read more.
From 11:00am until 6:00pm
From 9:00am until 12:00pm
“The Business of Science: Using SBIR Funding to Advance Research and Translation” Presented by Todd Brusko, Ph.D.
From 12:00pm until 1:00pm